首页> 外文会议>3rd ACM international workshop on data and text mining in bioinformatics 2009 >Multivariate Classification of Urine Metabolome Profiles for Breast Cancer Diagnosis
【24h】

Multivariate Classification of Urine Metabolome Profiles for Breast Cancer Diagnosis

机译:尿液代谢物谱的多分类对乳腺癌的诊断

获取原文
获取原文并翻译 | 示例

摘要

Diagnosis techniques using urine are non-invasive, inexpensive, and easy to perform in clinical settings. The metabolites in urine, as the end products of cellular processes, are closely linked to phenotypes. Although research using urine metabolome has many advantages, there can also be problems, such as multiple characteristic signals mixing or averaging into undistinguishable signals. As a result, it seems that univariate methods cannot identify precise boundaries between two groups, such as cancerous and normal samples. Moreover, due to individual differences in genetic makeup and heterogeneity in cancer progression, the analysis of combinatorial information from many variables seems to be more suitable than univariate analysis. In this study, we therefore propose classification models using multivariate classification techniques and develop an analysis procedure for classification studies using metabolome data. Through this strategy, we identified five potential urinary biomarkers for breast cancer with high accuracy and also proposed potential diagnosis rules to help in clinical decision making. After further validation with independent cohorts and experimental confirmation, these marker candidates will likely lead to clinically applicable assays for earlier diagnoses of breast cancer. This multivariate classification research is the second trial in metabolome analysis after Denkert et al. and the first for urine metabolome studies.
机译:使用尿液的诊断技术是非侵入性的,价格便宜,并且易于在临床环境中进行。尿中的代谢物作为细胞过程的最终产物,与表型密切相关。尽管使用尿液代谢组学的研究具有许多优势,但也可能存在问题,例如多个特征信号混合或平均为不可区别的信号。结果,单变量方法似乎无法识别出两组之间的精确界限,例如癌性样品和正常样品。此外,由于癌症构成中基因组成和异质性的个体差异,从许多变量中分析组合信息似乎比单变量分析更合适。因此,在这项研究中,我们提出了使用多元分类技术的分类模型,并开发了使用代谢组学数据进行分类研究的分析程序。通过这种策略,我们确定了五个潜在的乳腺癌尿液生物标志物,并提出了潜在的诊断规则,以帮助临床决策。经过独立队列的进一步验证和实验确认后,这些候选标记物可能会导致临床上可用于乳腺癌早期诊断的检测方法。这项多变量分类研究是继Denkert等人之后代谢组学分析的第二项试验。并首次用于尿液代谢组学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号